Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based drug discovery for Plasmodium falciparum.

Christopher Mehlin1

  • 1University of Washington, Structural Genomics of Pathogenic Protozoa, Box 357350 Department of Biochemistry, Seattle, WA 98195, USA. cmehlin@u.washington.edu

Combinatorial Chemistry & High Throughput Screening
|February 22, 2005
PubMed
Summary

X-ray crystallography aids antimalarial drug discovery by revealing Plasmodium falciparum protein structures. Despite challenges in protein production, this technique advances structure-based design for new malaria treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia.

Blood neoplasia·2026
Same author

Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies.

Cancers·2021
Same author

A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure.

Science translational medicine·2020
Same author

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.

Leukemia·2018
Same author

Screening, large-scale production and structure-based classification of cystine-dense peptides.

Nature structural & molecular biology·2018
Same author

Measurement of VLA-4/CS-1 and VLA-4/VCAM adhesion inhibition.

Current protocols in pharmacology·2012

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • X-ray crystallography is crucial for identifying novel antimalarial drug targets.
  • Obtaining sufficient protein quantities for crystallization presents significant challenges.
  • Plasmodium falciparum proteins are key targets in malaria research.

Purpose of the Study:

  • To review Plasmodium falciparum proteins crystallized with bound inhibitors.
  • To outline methodologies for heterologous expression of these proteins.
  • To discuss the application and limitations of structure-based drug discovery for malaria.

Main Methods:

  • Heterologous expression of Plasmodium falciparum proteins.
  • X-ray crystallography of proteins with bound inhibitors.

Related Experiment Videos

  • Structure-based drug design analysis.

    • Main Results:

    • Lactate dehydrogenase, plasmepsin II, and triosephosphate isomerase are advanced targets.
    • Nine additional Plasmodium falciparum proteins have been crystallized with inhibitors.
    • Structure-based drug design is a rapidly advancing field for antimalarial development.

    Conclusions:

    • X-ray crystallography is a valuable tool for antimalarial drug discovery.
    • Overcoming protein production hurdles is essential for crystallographic studies.
    • Structure-based approaches show promise but have limitations for known antimalarial drugs.